drugset / Trial / NCT06429657

Ketamine for Sedation in Severe Traumatic Brain Injury

NCT06429657

RandomizedParallel-groupOpen-labelTreatment

Summary

This protocol is for an open-label randomized trial evaluating the safety of using ketamine in combination with propofol for sedation versus the standard of care analgosedation in patients admitted to the intensive care unit with severe traumatic brain injury.

Timeline

Start
2024-09-23
Primary completion
2027-01-01
Completion
2027-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 1000 ug/kg
Subject Ketamine Small molecule 5000 ug/kg
Background Dexmedetomidine Other / unclassified
Background Fentanyl Other / unclassified
Background Hydromorphone Other / unclassified
Background Lorazepam Small molecule
Background Midazolam Small molecule
Background Morphine Other / unclassified
Background Propofol Small molecule 300 ug/kg
Background Propofol Small molecule